RevBio

RevBio is commercializing an injectable, self-setting, osteoconductive bone adhesive biomaterial capable of bonding bone-to-bone and bone-to-metal in wet field conditions. The company’s showcase product, Tetranite, is under FDA review for an increasing number of applications, including dental, craniofacial, orthopedic, and neurosurgical indications. Over time, this synthetic adhesive bio-degrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and improve patient outcomes by reducing recovery times and overall cost of care.